232 related articles for article (PubMed ID: 29080545)
1. Increased serum TREM-1 level is associated with in-stent restenosis, and activation of TREM-1 promotes inflammation, proliferation and migration in vascular smooth muscle cells.
Wang F; Li C; Ding FH; Shen Y; Gao J; Liu ZH; Chen JW; Zhang RY; Shen WF; Wang XQ; Lu L
Atherosclerosis; 2017 Dec; 267():10-18. PubMed ID: 29080545
[TBL] [Abstract][Full Text] [Related]
2. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin promotes intimal hyperplasia and contributes to in-stent restenosis: Role of an αVβ3/FAK dependent YAP pathway.
He Y; Zou P; Lu Y; Jia D; Li X; Yang H; Tang L; Zhu Z; Tu T; Tai S; Xiao Y; Chen M; Lu L; Zhou S
J Mol Cell Cardiol; 2020 Feb; 139():1-13. PubMed ID: 31958462
[TBL] [Abstract][Full Text] [Related]
4. Increment of HFABP Level in Coronary Artery In-Stent Restenosis Segments in Diabetic and Nondiabetic Minipigs: HFABP Overexpression Promotes Multiple Pathway-Related Inflammation, Growth and Migration in Human Vascular Smooth Muscle Cells.
Chen K; Chen QJ; Wang LJ; Liu ZH; Zhang Q; Yang K; Wang HB; Yan XX; Zhu ZB; Du R; Zhang RY; Shen WF; Lu L
J Vasc Res; 2016; 53(1-2):27-38. PubMed ID: 27372431
[TBL] [Abstract][Full Text] [Related]
5. Association of increased serum CTRP5 levels with in-stent restenosis after coronary drug-eluting stent implantation: CTRP5 promoting inflammation, migration and proliferation in vascular smooth muscle cells.
Shen Y; Li C; Zhang RY; Zhang Q; Shen WF; Ding FH; Lu L
Int J Cardiol; 2017 Feb; 228():129-136. PubMed ID: 27863353
[TBL] [Abstract][Full Text] [Related]
6. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells.
Lu L; Wang YN; Sun WH; Liu ZH; Zhang Q; Pu LJ; Yang K; Wang LJ; Zhu ZB; Meng H; Yang P; Du R; Chen QJ; Wang LS; Yu H; Shen WF
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):572-80. PubMed ID: 23372061
[TBL] [Abstract][Full Text] [Related]
7. The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro.
Kastl SP; Katsaros KM; Krychtiuk KA; Jägersberger G; Kaun C; Huber K; Wojta J; Speidl WS
PLoS One; 2020; 15(5):e0232483. PubMed ID: 32392256
[TBL] [Abstract][Full Text] [Related]
8. Euonymine inhibits in-stent restenosis through enhancing contractile phenotype of vascular smooth muscle cells via modulating the PTEN/AKT/mTOR signaling pathway.
Zhang L; Tao Y; Yang R; Hu Q; Jia J; Yu M; He B; Shen Z; Qin H; Yu Z; Chen P
Phytomedicine; 2022 Dec; 107():154450. PubMed ID: 36174454
[TBL] [Abstract][Full Text] [Related]
9. A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis.
Méndez-Barbero N; Gutierrez-Muñoz C; Madrigal-Matute J; Mínguez P; Egido J; Michel JB; Martín-Ventura JL; Esteban V; Blanco-Colio LM
EBioMedicine; 2019 Aug; 46():274-289. PubMed ID: 31395500
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.
Du C; Peng L; Kou G; Wang P; Lu L; Li Y
Dig Dis Sci; 2018 May; 63(5):1182-1191. PubMed ID: 29516326
[TBL] [Abstract][Full Text] [Related]
11. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule.
Kuwano T; Miura S; Shirai K; Ike A; Mori K; Shimizu T; Zhang B; Iwata A; Nishikawa H; Kawamura A; Saku K
J Atheroscler Thromb; 2011; 18(7):574-83. PubMed ID: 21427507
[TBL] [Abstract][Full Text] [Related]
13. Increase of ADAM10 level in coronary artery in-stent restenosis segments in diabetic minipigs: high ADAM10 expression promoting growth and migration in human vascular smooth muscle cells via Notch 1 and 3.
Yang K; Lu L; Liu Y; Zhang Q; Pu LJ; Wang LJ; Zhu ZB; Wang YN; Meng H; Zhang XJ; Du R; Chen QJ; Shen WF
PLoS One; 2013; 8(12):e83853. PubMed ID: 24386293
[TBL] [Abstract][Full Text] [Related]
14. c-kit-immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions.
Hibbert B; Chen YX; O'Brien ER
Am J Physiol Heart Circ Physiol; 2004 Aug; 287(2):H518-24. PubMed ID: 15277195
[TBL] [Abstract][Full Text] [Related]
15. Stainless steel ions stimulate increased thrombospondin-1-dependent TGF-beta activation by vascular smooth muscle cells: implications for in-stent restenosis.
Pallero MA; Talbert Roden M; Chen YF; Anderson PG; Lemons J; Brott BC; Murphy-Ullrich JE
J Vasc Res; 2010; 47(4):309-22. PubMed ID: 20016205
[TBL] [Abstract][Full Text] [Related]
16. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
17. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin inhibits human in stent restenosis vascular smooth muscle cells independently of pRB phosphorylation and p53.
Rosner D; McCarthy N; Bennett M
Cardiovasc Res; 2005 Jun; 66(3):601-10. PubMed ID: 15914125
[TBL] [Abstract][Full Text] [Related]
19. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
[TBL] [Abstract][Full Text] [Related]
20. XAV939 Inhibits Intima Formation by Decreasing Vascular Smooth Muscle Cell Proliferation and Migration Through Blocking Wnt Signaling.
Chen L; Zhuang J; Singh S; Wang K; Xiong M; Xu D; Chen W; Pang J; Xu Y; Li X
J Cardiovasc Pharmacol; 2016 Dec; 68(6):414-424. PubMed ID: 27525574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
